Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15920021rdf:typepubmed:Citationlld:pubmed
pubmed-article:15920021lifeskim:mentionsumls-concept:C0376466lld:lifeskim
pubmed-article:15920021lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:15920021lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:15920021lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:15920021pubmed:issue12lld:pubmed
pubmed-article:15920021pubmed:dateCreated2005-6-24lld:pubmed
pubmed-article:15920021pubmed:abstractTextPhosphorylation and subsequent inactivation of glycogen synthase kinase (GSK)-3beta via the Akt/PI3-Kinase pathway during ischemic preconditioning (PC) has been shown to be cardioprotective. As FrzA/sFRP-1, a secreted antagonist of the Wnt/Frizzled pathway, is expressed in the heart and is able to decrease the phosphorylation of GSK-3beta in vitro on vascular cells, we examined its effect during PC using transgenic mouse overexpressing FrzA in cardiomyocytes (alpha-MHC promoter) under a conditional transgene expression approach (tet-off system). Overexpression of FrzA inhibited the increase in GSK-3beta phosphorylation as well as protein kinase C (PKC) epsilon activation in transgenic mice after PC as compared with littermates. Phospho-Akt (P-Akt), phospho-JNK, or the cytoplasmic beta-catenin levels were not modified, phospho-p38 (P-p38) was slightly increased in transgenic mice after PC as compared with littermates. FrzA transgenic mice displayed a larger infarct size and a greater worsening of cardiac function compared with littermates. All these differences were reversed by the addition of doxycycline. This study demonstrates for the first time that disruption of a beta-catenin independent Wnt/Frizzled pathway induces the activation of GSK-3beta and reverses the benefit of preconditioning.lld:pubmed
pubmed-article:15920021pubmed:languageenglld:pubmed
pubmed-article:15920021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:citationSubsetIMlld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920021pubmed:statusMEDLINElld:pubmed
pubmed-article:15920021pubmed:monthJunlld:pubmed
pubmed-article:15920021pubmed:issn1524-4571lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:Dos...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:DaretDanièleDlld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:DufourcqPasca...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:CouffinhalThi...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:MoreauCatheri...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:DuplàaCécileClld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:CostetPierrePlld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:BarandonLaure...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:AllièresCécil...lld:pubmed
pubmed-article:15920021pubmed:authorpubmed-author:Daniel...lld:pubmed
pubmed-article:15920021pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15920021pubmed:day24lld:pubmed
pubmed-article:15920021pubmed:volume96lld:pubmed
pubmed-article:15920021pubmed:ownerNLMlld:pubmed
pubmed-article:15920021pubmed:authorsCompleteYlld:pubmed
pubmed-article:15920021pubmed:pagination1299-306lld:pubmed
pubmed-article:15920021pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:meshHeadingpubmed-meshheading:15920021...lld:pubmed
pubmed-article:15920021pubmed:year2005lld:pubmed
pubmed-article:15920021pubmed:articleTitleInvolvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning.lld:pubmed
pubmed-article:15920021pubmed:affiliationDepartment of Cardiovascular Surgery, Hôpital Haut Lévêque, Pessac, France.lld:pubmed
pubmed-article:15920021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15920021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15920021lld:pubmed